Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

CYCCP Quote, Trading Chart, Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock


home / stock / cyccp / cyccp quote

$ Last:

Change Percent:

$ Open:

$ Previous Close:

$ High:

$ Low:

0 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-02-267.67.4587.45554
2021-02-237.387.387.387.38100
2021-02-227.357.357.357.35300
2021-02-167.55887.55488
2021-02-158.1988.198387
2021-02-128.1988.198387
2021-02-118.27.58.27.52,408
2021-02-098.998.28.998.2600
2021-02-039.29.29.29.2229
2021-02-018.428.00018.468.00011,189
2021-01-189.249.29.249.2203
2021-01-159.249.29.249.2203
2021-01-1498.49.0458.41,300
2021-01-138.568.568.568.56420
2021-01-128.598.598.598.59100
2021-01-118.998.5598.451,493
2021-01-068.958.58.958.4800
2021-01-058.799.358.72,759
2021-01-017.037.037.037.03206
2020-12-317.037.037.037.03206
Stock Information

Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock Company Name:

CYCCP Stock Symbol:

NASDAQ Market:

MENU
CYCCP CYCCP Quote CYCCP Short CYCCP News CYCCP Articles CYCCP Message Board
Get CYCCP Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT CYCCP NEWS
  • CYCCP - Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

    BERKELEY HEIGHTS, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") a biopharmaceutical company developing innovative medicines based on cancer cell biology, today reported its financial results and business hig...

  • CYCCP - Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2020 Financial Results

    BERKELEY HEIGHTS, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce fourth quarter and full year 2020 fina...

  • CYCCP - Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference

    BERKELEY HEIGHTS, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at the...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News